Loading Nexium blister strips onto packing line, Tablets Manufacturing, Macclesfield, UK / Courtesy of AstraZeneca
The US Food and Drug Administration (FDA) has approved an application by pharmaceutical company Teva to market a generic version of AstraZeneca’s heartburn drug Nexium (esomeprazole magnesium).
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at firstname.lastname@example.org
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Teva, AstraZeneca, Nexium, generic, FDA